LOGIN
ID
PW
MemberShip
2025-07-08 21:14
All News
Policy
Company
Product
Opinion
InterView
°Ë»ö
Dailypharm Live Search
Close
NOVARTIS 2018 Annualreport
NOVARTIS 2018 Annualreport
Input Time : 2019-12-23
[Download file]
go back
OPINION
[Reporter¡¯s View] NHI finances and reimb expansions
Reporter's view |
Lee, Jeong-Hwan
[Reporter¡¯s View] Doctors agree Korea¡¯s reimb is too slow
Reporter's view |
Eo, Yun-Ho
[Reporter's View] Divisional restructuring needed
Reporter's view |
Lee, Hye-Kyung
INTERVIEW
V-olet challenges to become a blockbuster fat-destroying inj
Kim Seul-ki, PM of Daewoong Pharmaceutical's Nabota Business Team
'Viatris will lead market with innovation and leadership'
Bill Schuster, Representative Director & Country Manager of Viatris Korea
"Livtencity offers new CMV trt for transplant patients"
Dr. Sang-Oh Lee, professor at Seoul Asan Medical Center's Department of Infectious Diseases
¡®SGLT2i+TZD promising for diabetics with fatty liver risk¡¯
Cheol-Young Park, Professor of Endocrinology at Kangbuk Samsung Hospital
Hemlibra shows long-term efficacy and safety in hemophilia
Long-term prevention of bleeding episodes
Data
Roche 2018 Annualreport
Roche 2018 Annualreport
NOVARTIS 2018 Annualreport
NOVARTIS 2018 Annualreport
2018 Multinational Pharma Sales
2018 Multinational Pharma Sales
MOST READ
1
PCV21 emerges¡¦evidence-based vaccination policies discussed
2
MFDS reviews GMP standards for sterile preparations abroad
3
¡®Need to institutionalize reinvestment of funds into R&D'
4
PKU drug Sephience receives orphan drug designation in KOR
5
Boryung's follow-on Lenvima, 'Lenvanib,' becomes reimbursed
6
MFDS reviews emergency import of 'anakinra'
7
Novo Nordisk's injectables are in short supply
8
Industry requests postponement of drug reimbursement reevals
9
V-olet challenges to become a blockbuster fat-destroying inj
10
Low-strength salt-modified Pristiq now available